Percheron Therapeutics Ltd
AWY0
Company Profile
Business description
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Contact
14 Wallace Avenue
LEVEL 1
ToorakVIC3142
AUST: +61 398278999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
8
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,462.60 | 40.90 | 0.49% |
CAC 40 | 7,733.11 | 38.67 | 0.50% |
DAX 40 | 23,486.09 | 133.40 | 0.57% |
Dow JONES (US) | 41,368.45 | 254.48 | 0.62% |
FTSE 100 | 8,568.60 | 36.99 | 0.43% |
HKSE | 22,867.74 | 91.82 | 0.40% |
NASDAQ | 17,928.14 | 189.98 | 1.07% |
Nikkei 225 | 37,503.33 | 574.70 | 1.56% |
NZX 50 Index | 12,605.07 | 138.04 | 1.11% |
S&P 500 | 5,663.94 | 32.66 | 0.58% |
S&P/ASX 200 | 8,231.20 | 39.50 | 0.48% |
SSE Composite Index | 3,342.00 | 10.00 | -0.30% |